These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4840677)

  • 1. [Drug stability in lyophilic suppository media].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(2):257-8. PubMed ID: 4840677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on stability of drugs in lyophilized suppository bases. 1. Separation and detection of products of decomposition of cyclovegantine, ethionamide and euphylline by means of thin-layer chromatography].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(1):59-69. PubMed ID: 5577813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the stability of drugs in lyophilic suppository media. II. Evaluation of decay of cyclovegantine, ethionamide and euphylline in suppositories].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(4):375-84. PubMed ID: 5145789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
    [No Abstract]   [Full Text] [Related]  

  • 5. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug stability in lyophilic suppository bases. VI. Identification of euphylline decay products isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1975; 32(3):371-7. PubMed ID: 1155194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stability of drugs in lyophilic suppository bases. IV. Identification of decomposition products of cyclovegantine isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(1):99-107. PubMed ID: 4151652
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases].
    Pawelczyk E; Zajac M
    Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability study of aminophylline suppositories. Part I: Decomposition products and specific assay method for ethylenediamine.
    van Dop C; Overvliet GM; Smits HM
    Pharm Acta Helv; 1981; 56(9-10):281-4. PubMed ID: 7291212
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physical stability of suppository bases at different temperatures].
    Leszczyńska-Bakal H
    Acta Pol Pharm; 1971; 28(5):531-5. PubMed ID: 5145101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Choice of bases for suppositories with antibiotics. I. Stability of antibiotics in suppository bases].
    Zaremba A; Krówczyński L
    Acta Pol Pharm; 1974; 31(6):769-73. PubMed ID: 4447038
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of method of preparation on pharmaceutical availability of aminophylline suppositories].
    Knapczyk J; Starosta B; Bitner J
    Folia Med Cracov; 1979; 21(1):149-56. PubMed ID: 396189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kinetics of drug decomposition. LXXII. Stability of the preparation Clofenazon in the suppository base Vitepsol H-15].
    Pawełczyk E; Wachowiak R; Babelek T
    Acta Pol Pharm; 1982; 39(5-6):381-6. PubMed ID: 6133411
    [No Abstract]   [Full Text] [Related]  

  • 14. Rectal administration of drugs.
    Senior N
    Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
    [No Abstract]   [Full Text] [Related]  

  • 15. Decomposition of aminophylline in suppository formulations.
    Brower JF; Juenge EC; Page DP; Dow ML
    J Pharm Sci; 1980 Aug; 69(8):942-5. PubMed ID: 7400941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T; Kubota A; Togawa K; Mizushima N
    Tokai J Exp Clin Med; 1982 May; 7(3):371-83. PubMed ID: 7123575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed proton NMR and solid-liquid fat ratio determinations in suppository vehicles and aminophylline suppositories.
    De Blaey CJ; Varkevisser FA; Kalk A
    Pharm Weekbl Sci; 1984 Oct; 6(5):203-8. PubMed ID: 6504688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of excipients and storage conditions on drug preservation. IV. Suppositories with acetyl salicylic acid base].
    Delonca H; Puech A; Segura G; Joachim J
    J Pharm Belg; 1972; 27(1):50-6. PubMed ID: 5017455
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical stability of semisynthetic suppository bases.
    Coben LJ; Lordi NG
    J Pharm Sci; 1980 Aug; 69(8):955-60. PubMed ID: 7400945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of lipophilic emulsifiers on the drug-output from cocoa-butter prepared suppositories].
    Mezey G
    Pharmazie; 1971 Mar; 26(3):166-9. PubMed ID: 5574492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.